Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-12759 Ophthalmic Suspension in Keratoconjunctival Epithelial Disorder
jRCT2080221666Phase 2
- Sponsor
- Otsuka Holdings
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of rebamipide in superficial punctate keratitis (SPK), corneal erosion and Keratoconjunctivitis (KC) (2 arms), sponsored by Otsuka Holdings.
02
Drugs
rebamipide
03
Conditions
superficial punctate keratitis (SPK)corneal erosionKeratoconjunctivitis (KC)
Beyond the preview
Go deeper on jRCT2080221666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221666.